My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 123

    1.

    Neurologic symptoms associated with parenteral acyclovir treatment after marrow transplantation.

    Wade JC, Meyers JD.

    Ann Intern Med. 1983 Jun;98(6):921-5.PMID: 6305245 [PubMed - indexed for MEDLINE]Related articles

    2.

    [Neurologic effects of acyclovir after an allogenic marrow graft]

    Burguet A, Menget A, Fromentin C, Plouvier E, Amsallem D, Noir A, Lokiec F.

    Arch Fr Pediatr. 1988 May;45(5):343-5. French. PMID: 2843139 [PubMed - indexed for MEDLINE]Related articles

    3.

    [Oral prophylaxis of herpes infections using acyclovir following bone marrow transplantation: a clinical and clinico-pharmacological study]

    Ehninger G, Vallbracht A, Schüch K, Kumbier I, Dopfer R, Schmidt H, Ostendorf P.

    Klin Wochenschr. 1986 Jun 16;64(12):570-4. German. PMID: 2426515 [PubMed - indexed for MEDLINE]Related articles

    4.

    Treatment of cytomegaloviral pneumonia with high-dose acyclovir and human leukocyte interferon.

    Wade JC, McGuffin RW, Springmeyer SC, Newton B, Singer JW, Meyers JD.

    J Infect Dis. 1983 Sep;148(3):557-62.PMID: 6311916 [PubMed - indexed for MEDLINE]Related articles

    5.

    Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation.

    Wade JC, Newton B, Flournoy N, Meyers JD.

    Ann Intern Med. 1984 Jun;100(6):823-8.PMID: 6326632 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Acyclovir in the therapy of herpesvirus infections]

    Osterwalder B, Gratwohl A, Bannert P, Nissen C, Speck B.

    Schweiz Med Wochenschr. 1984 Jan 7;114(1):14-5. German. PMID: 6320361 [PubMed - indexed for MEDLINE]Related articles

    7.

    The use of acyclovir for cytomegalovirus infections in the immunocompromised host.

    Meyers JD, Wade JC, McGuffin RW, Springmeyer SC, Thomas ED.

    J Antimicrob Chemother. 1983 Sep;12 Suppl B:181-93. Review.PMID: 6313597 [PubMed - indexed for MEDLINE]Related articles

    8.

    European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

    Reusser P, Cordonnier C, Einsele H, Engelhard D, Link D, Locasciulli A, Ljungman P.

    Bone Marrow Transplant. 1996 May;17(5):813-7.PMID: 8733703 [PubMed - indexed for MEDLINE]Related articles

    9.

    Implementation and evaluation of a standardized herpes simplex virus prophylaxis protocol on a leukemia/bone marrow transplant unit.

    Rayani SA, Nimmo CJ, Frighetto L, Martinusen SM, Nickoloff DM, Reece DE, Jewesson PJ.

    Ann Pharmacother. 1994 Jul-Aug;28(7-8):852-6.PMID: 7949499 [PubMed - indexed for MEDLINE]Related articles

    10.

    Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance?

    Wang FZ, Linde A, Hägglund H, Testa M, Locasciulli A, Ljungman P.

    Clin Infect Dis. 1999 Mar;28(3):562-8.PMID: 10194079 [PubMed - indexed for MEDLINE]Related articles

    11.

    Acute acyclovir neurotoxicity in a hemodialyzed child.

    Strong DK, Hébert D.

    Pediatr Nephrol. 1997 Dec;11(6):741-3.PMID: 9438656 [PubMed - indexed for MEDLINE]Related articles

    12.

    Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.

    Rubin RH, Kemmerly SA, Conti D, Doran M, Murray BM, Neylan JF, Pappas C, Pitts D, Avery R, Pavlakis M, Del Busto R, DeNofrio D, Blumberg EA, Schoenfeld DA, Donohue T, Fisher SA, Fishman JA.

    Transpl Infect Dis. 2000 Sep;2(3):112-7.PMID: 11429021 [PubMed - indexed for MEDLINE]Related articles

    13.

    Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial.

    Hann IM, Prentice HG, Blacklock HA, Ross MG, Brigden D, Rosling AE, Burke C, Crawford DH, Brumfitt W, Hoffbrand AV.

    Br Med J (Clin Res Ed). 1983 Aug 6;287(6389):384-8.PMID: 6307464 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Encephalitis caused by human herpesvirus-6 in transplant recipients: relevance of a novel neurotropic virus.

    Singh N, Paterson DL.

    Transplantation. 2000 Jun 27;69(12):2474-9.PMID: 10910264 [PubMed - indexed for MEDLINE]Related articles

    15.

    Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study.

    Graus F, Saiz A, Sierra J, Arbaiza D, Rovira M, Carreras E, Tolosa E, Rozman C.

    Neurology. 1996 Apr;46(4):1004-9.PMID: 8780080 [PubMed - indexed for MEDLINE]Related articles

    16.

    Combined antiviral and immunoglobulin therapy as prophylaxis against cytomegalovirus infection after heart transplantation.

    Valenza M, Czer LS, Pan SH, Aleksic I, Freimark D, Harasty DA, Admon D, Barath P, Blanche C, Trento A.

    J Heart Lung Transplant. 1995 Jul-Aug;14(4):659-65.PMID: 7578172 [PubMed - indexed for MEDLINE]Related articles

    17.

    Acyclovir treatment of varicella-zoster virus infection in the compromised host.

    Meyers JD, Wade JC, Shepp DH, Newton B.

    Transplantation. 1984 Jun;37(6):571-4.PMID: 6328703 [PubMed - indexed for MEDLINE]Related articles

    18.

    Immediate and delayed neurotoxicity after mechlorethamine preparation for bone marrow transplantation.

    Sullivan KM, Storb R, Shulman HM, Shaw CM, Spence A, Beckham C, Clift RA, Buckner CD, Stewart P, Thomas ED.

    Ann Intern Med. 1982 Aug;97(2):182-9.PMID: 7049028 [PubMed - indexed for MEDLINE]Related articles

    19.

    Acyclovir treatment of herpes zoster infections. Use in children undergoing bone marrow transplantation.

    Serota FT, Starr SE, Bryan CK, Koch PA, Plotkin SA, August CS.

    JAMA. 1982 Apr 16;247(15):2132-5.PMID: 7038177 [PubMed - indexed for MEDLINE]Related articles

    20.

    Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.

    Winston DJ, Busuttil RW.

    Transplantation. 2003 Jan 27;75(2):229-33.PMID: 12548129 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity